EC: 2.3.2.2
gamma-glutamyltransferase ((5-L-glutamyl)-peptide:amino-acid 5-glutamyltransferase)
Pathways
| pathway id | name |
|---|---|
| BioCyc:HUMAN_PWY-4061 | glutathione-mediated detoxification I |
| BioCyc:META_PWY-6842 | glutathione-mediated detoxification II |
| BioCyc:YEAST_PWY-6842-1 | glutathione-mediated detoxification II |
| BioCyc:HUMAN_PWY66-375 | leukotriene biosynthesis |
| BioCyc:HUMAN_PWY-4041 | γ-glutamyl cycle |
| BioCyc:META_PWY-4041 | γ-glutamyl cycle |
| BioCyc:META_PWY-4061 | glutathione-mediated detoxification I |
| BioCyc:YEAST_PWY-7559 | glutathione degradation (DUG pathway) |
| BioCyc:ARA_PWY-6842 | glutathione-mediated detoxification II |
| BioCyc:ARA_PWY-4041 | γ-glutamyl cycle |
| BioCyc:MOUSE_PWY-4041 | γ-glutamyl cycle |
| BioCyc:ARA_PWYQT-4432 | glutathione degradation |
| BioCyc:META_PWY66-375 | leukotriene biosynthesis |
| BioCyc:META_PWY-7559 | glutathione degradation (DUG pathway - yeast) |
| BioCyc:ARA_PWY-6745 | phytochelatins biosynthesis |
| PlantCyc:ARA_PWY-4041 | γ-glutamyl cycle |
| PlantCyc:ARA_PWY-6842 | glutathione-mediated detoxification II |
| PlantCyc:ARA_PWY-6745 | phytochelatins biosynthesis |
| PlantCyc:PLANT_PWYQT-4432 | glutathione degradation |
| PlantCyc:PLANT_PWY-4041 | γ-glutamyl cycle |
| PlantCyc:PLANT_PWY-6842 | glutathione-mediated detoxification II |
| PlantCyc:ARA_PWYQT-4432 | glutathione degradation |
| Reactome:R-BTA-9748784 | Drug ADME |
| Reactome:R-MMU-9753281 | APAP ADME |
| Reactome:R-RNO-9748784 | Drug ADME |
| Reactome:R-SCE-9748784 | Drug ADME |
| Reactome:R-BTA-9753281 | APAP ADME |
| Reactome:R-RNO-9753281 | APAP ADME |
| Reactome:R-SCE-9753281 | APAP ADME |
| Reactome:R-SPO-9748784 | Drug ADME |
| Reactome:R-HSA-9658195 | Leishmania infection |
| Reactome:R-HSA-9664433 | Leishmania parasite growth and survival |
| Reactome:R-HSA-9753281 | APAP ADME |
| Reactome:R-MMU-9748784 | Drug ADME |
| Reactome:R-HSA-9662851 | Anti-inflammatory response favouring Leishmania parasite infection |
| Reactome:R-HSA-9664535 | LTC4-CYSLTR mediated IL4 production |
| Reactome:R-HSA-9748784 | Drug ADME |
| Reactome:R-SPO-9753281 | APAP ADME |
| Reactome:R-HSA-9824443 | Parasitic Infection Pathways |
| Reactome:R-BTA-1430728 | Metabolism |
| Reactome:R-BTA-156590 | Glutathione conjugation |
| Reactome:R-HSA-2142691 | Synthesis of Leukotrienes (LT) and Eoxins (EX) |
| Reactome:R-HSA-211859 | Biological oxidations |
| Reactome:R-HSA-5423646 | Aflatoxin activation and detoxification |
| Reactome:R-HSA-1643685 | Disease |
| Reactome:R-MMU-1430728 | Metabolism |
| Reactome:R-MMU-556833 | Metabolism of lipids |
| Reactome:R-MMU-2142691 | Synthesis of Leukotrienes (LT) and Eoxins (EX) |
| Reactome:R-MMU-211859 | Biological oxidations |
| Reactome:R-MMU-5423646 | Aflatoxin activation and detoxification |
| Reactome:R-RNO-8978868 | Fatty acid metabolism |
| Reactome:R-RNO-156590 | Glutathione conjugation |
| Reactome:R-SCE-2142691 | Synthesis of Leukotrienes (LT) and Eoxins (EX) |
| Reactome:R-SPO-1430728 | Metabolism |
| Reactome:R-SPO-2142691 | Synthesis of Leukotrienes (LT) and Eoxins (EX) |
| Reactome:R-SPO-5423646 | Aflatoxin activation and detoxification |
| Reactome:R-BTA-211859 | Biological oxidations |
| Reactome:R-BTA-5423646 | Aflatoxin activation and detoxification |
| Reactome:R-HSA-556833 | Metabolism of lipids |
| Reactome:R-HSA-8978868 | Fatty acid metabolism |
| Reactome:R-HSA-156580 | Phase II - Conjugation of compounds |
| Reactome:R-MMU-8978868 | Fatty acid metabolism |
| Reactome:R-MMU-156580 | Phase II - Conjugation of compounds |
| Reactome:R-RNO-2142753 | Arachidonate metabolism |
| Reactome:R-RNO-211859 | Biological oxidations |
| Reactome:R-RNO-5423646 | Aflatoxin activation and detoxification |
| Reactome:R-SCE-1430728 | Metabolism |
| Reactome:R-SCE-8978868 | Fatty acid metabolism |
| Reactome:R-SCE-174403 | Glutathione synthesis and recycling |
| Reactome:R-SPO-8978868 | Fatty acid metabolism |
| Reactome:R-SPO-211859 | Biological oxidations |
| Reactome:R-SPO-174403 | Glutathione synthesis and recycling |
| Reactome:R-BTA-174403 | Glutathione synthesis and recycling |
| Reactome:R-HSA-156590 | Glutathione conjugation |
| Reactome:R-MMU-156590 | Glutathione conjugation |
| Reactome:R-RNO-1430728 | Metabolism |
| Reactome:R-RNO-556833 | Metabolism of lipids |
| Reactome:R-RNO-2142691 | Synthesis of Leukotrienes (LT) and Eoxins (EX) |
| Reactome:R-RNO-174403 | Glutathione synthesis and recycling |
| Reactome:R-SCE-556833 | Metabolism of lipids |
| Reactome:R-SCE-156580 | Phase II - Conjugation of compounds |
| Reactome:R-SCE-5423646 | Aflatoxin activation and detoxification |
| Reactome:R-SPO-156580 | Phase II - Conjugation of compounds |
| Reactome:R-BTA-156580 | Phase II - Conjugation of compounds |
| Reactome:R-HSA-1430728 | Metabolism |
| Reactome:R-HSA-2142753 | Arachidonate metabolism |
| Reactome:R-HSA-174403 | Glutathione synthesis and recycling |
| Reactome:R-HSA-5663205 | Infectious disease |
| Reactome:R-MMU-2142753 | Arachidonate metabolism |
| Reactome:R-MMU-174403 | Glutathione synthesis and recycling |
| Reactome:R-RNO-156580 | Phase II - Conjugation of compounds |
| Reactome:R-SCE-2142753 | Arachidonate metabolism |
| Reactome:R-SCE-211859 | Biological oxidations |
| Reactome:R-SCE-156590 | Glutathione conjugation |
| Reactome:R-SPO-556833 | Metabolism of lipids |
| Reactome:R-SPO-2142753 | Arachidonate metabolism |
| Reactome:R-SPO-156590 | Glutathione conjugation |
| WikiPathways:WP4518 | Gamma-glutamyl cycle for the biosynthesis and degradation of glutathione, including diseases |
| PathBank:SMP0120480 | gamma-Glutamyltransferase Deficiency |
| PathBank:SMP0120565 | 5-Oxoprolinase Deficiency |
| PathBank:SMP0121212 | Camalexin Biosynthesis |
| PathBank:SMP0000015 | Glutathione Metabolism |
| PathBank:SMP0000083 | Acetylsalicylic Acid Action Pathway |
| PathBank:SMP0000087 | Rofecoxib Action Pathway |
| PathBank:SMP0000094 | Sulindac Action Pathway |
| PathBank:SMP0000104 | Indomethacin Action Pathway |
| PathBank:SMP0000120 | Naproxen Action Pathway |
| PathBank:SMP0000106 | Meloxicam Action Pathway |
| PathBank:SMP0000500 | 5-Oxoprolinase Deficiency |
| PathBank:SMP0000693 | Antrafenine Action Pathway |
| PathBank:SMP0000697 | Flurbiprofen Action Pathway |
| PathBank:SMP0000701 | Phenylbutazone Action Pathway |
| PathBank:SMP0000705 | Tiaprofenic Acid Action Pathway |
| PathBank:SMP0000709 | Salicylic Acid Action Pathway |
| PathBank:SMP0120705 | Glutathione Synthetase Deficiency |
| PathBank:SMP0120785 | gamma-Glutamyltranspeptidase Deficiency |
| PathBank:SMP0000075 | Arachidonic Acid Metabolism |
| PathBank:SMP0000086 | Ibuprofen Action Pathway |
| PathBank:SMP0000093 | Diclofenac Action Pathway |
| PathBank:SMP0000098 | Ketorolac Action Pathway |
| PathBank:SMP0000102 | Bromfenac Action Pathway |
| PathBank:SMP0000114 | Nabumetone Action Pathway |
| PathBank:SMP0000692 | Antipyrine Action Pathway |
| PathBank:SMP0000696 | Fenoprofen Action Pathway |
| PathBank:SMP0000700 | Lornoxicam Action Pathway |
| PathBank:SMP0000704 | Tolmetin Action Pathway |
| PathBank:SMP0000708 | Salicylate-Sodium Action Pathway |
| PathBank:SMP0002317 | Glutathione Metabolism |
| PathBank:SMP0087277 | Glutathione Metabolism |
| PathBank:SMP0087309 | Taurine and Hypotaurine Metabolism |
| PathBank:SMP0063587 | Selenoamino Acid Metabolism |
| PathBank:SMP0063595 | Arachidonic Acid Metabolism |
| PathBank:SMP0120700 | gamma-Glutamyltransferase Deficiency |
| PathBank:SMP0120784 | 5-Oxoprolinase Deficiency |
| PathBank:SMP0120485 | Glutathione Synthetase Deficiency |
| PathBank:SMP0120566 | gamma-Glutamyltranspeptidase Deficiency |
| PathBank:SMP0000337 | Glutathione Synthetase Deficiency |
| PathBank:SMP0000077 | Piroxicam Action Pathway |
| PathBank:SMP0000084 | Etodolac Action Pathway |
| PathBank:SMP0000109 | Mefenamic Acid Action Pathway |
| PathBank:SMP0000289 | Diflunisal Action Pathway |
| PathBank:SMP0000116 | Valdecoxib Action Pathway |
| PathBank:SMP0000501 | gamma-Glutamyltranspeptidase Deficiency |
| PathBank:SMP0000694 | Carprofen Action Pathway |
| PathBank:SMP0000698 | Magnesium Salicylate Action Pathway |
| PathBank:SMP0000702 | Nepafenac Action Pathway |
| PathBank:SMP0000706 | Tenoxicam Action Pathway |
| PathBank:SMP0000710 | Acetaminophen Action Pathway |
| PathBank:SMP0087167 | Glutathione Metabolism |
| PathBank:SMP0120667 | 5-Oxoprolinuria |
| PathBank:SMP0120446 | 5-Oxoprolinuria |
| PathBank:SMP0120510 | Leukotriene C4 Synthesis Deficiency |
| PathBank:SMP0000029 | Selenoamino Acid Metabolism |
| PathBank:SMP0000021 | Taurine and Hypotaurine Metabolism |
| PathBank:SMP0000143 | 5-Oxoprolinuria |
| PathBank:SMP0000183 | gamma-Glutamyltransferase Deficiency |
| PathBank:SMP0000353 | Leukotriene C4 Synthesis Deficiency |
| PathBank:SMP0000085 | Ketoprofen Action Pathway |
| PathBank:SMP0000096 | Celecoxib Action Pathway |
| PathBank:SMP0000101 | Suprofen Action Pathway |
| PathBank:SMP0000113 | Oxaprozin Action Pathway |
| PathBank:SMP0000695 | Etoricoxib Action Pathway |
| PathBank:SMP0000699 | Lumiracoxib Action Pathway |
| PathBank:SMP0000703 | Trisalicylate-Choline Action Pathway |
| PathBank:SMP0000707 | Salsalate Action Pathway |
| PathBank:SMP0087214 | Taurine and Hypotaurine Metabolism |
| PathBank:SMP0063622 | Glutathione Metabolism |
| PathBank:SMP0063675 | Taurine and Hypotaurine Metabolism |